US healthcare is a $4.5T industry where patients have no prices and providers have no way to fill idle capacity. MedBid fixes both, with a mechanism, not just a mandate.
1.15M
Hospital lawsuits filed against patients in Virginia alone (15-year study)
43%
Of hospitals now posting fewer prices than last year despite federal law requiring full disclosure
39%
Average gap: cash prices are 39% cheaper than insurer-negotiated rates, yet patients rarely know
$4.5T
Total US healthcare spend: the world's largest single market
$59.5B
Direct Primary Care market (2024), growing to $92.9B by 2034: MedBid's core provider supply
$7.35B
Concierge medicine market (2024), 10.33% CAGR through 2030: cash-pay providers with structural idle capacity
1M+
CBO-projected Americans shifting to self-pay or uninsured status following ACA enhanced subsidy expiration
Regulatory Tailwind
The government is building MedBid's market for us.
Three concurrent regulatory and legislative forces are driving patients toward price-transparent, cash-pay alternatives: exactly what MedBid delivers.
Active in 2026 Congress
Legislation
Patients Deserve Price Tags Act
Bipartisan support in both House and Senate. Would codify existing transparency rules and expand mandatory disclosure requirements, normalizing the expectation that prices are knowable before care.
Announced Q1 2026
Executive Action
HHS Federal Hospital Price List
HHS Secretary Kennedy announced the federal government will host a public hospital service price list. Any provider accepting Medicare or Medicaid must post prices publicly, driving demand for tools that help patients act on that data.
January 1, 2026
Market Shock
ACA Subsidy Expiration
The expiration of enhanced ACA premium tax credits at the end of 2025 caused marketplace premiums to rise sharply for subsidy-receiving enrollees. CBO projections estimated millions would become uninsured or shift to self-pay over a multi-year window.
Competitive Landscape
How MedBid's model differs
Capability
Fixed-price platforms*
Bundled-price platforms*
Early reverse-auction*
MedBid
Transparent pricing
✓
✓
✓
✓
Providers compete on each bid in real time
—
—
Partial
✓
Patient posts a target price
—
—
—
✓
Live bid notifications (push/SMS/email)
—
—
—
✓
ZIP-radius slot matching
Varies
Varies
Varies
✓
B2B / employer offering
Varies
✓
—
✓
Proprietary reverse-bid price dataset
—
—
—
✓
Native bilingual EN/ES patient UX
Varies
Varies
Varies
✓
No subscription fee for patients
Varies
✓
Varies
✓
The Data Advantage
A proprietary dataset that deepens with every transaction
LAYER 01
Sub-benchmark transaction prices
Public datasets (CMS, chargemasters) show what providers bill. MedBid is designed to capture what providers actually accept in a competitive cash market. As the platform scales, each accepted bid becomes a real transaction-price datapoint, building a dataset of actual cash-market clearing prices that public data sources cannot capture.
LAYER 02
Procedure × geography × time
Prices vary by ZIP code, specialty, provider size, and season. As MedBid accumulates transactions, the dataset maps these dimensions, ultimately enabling fine-grained geographic price intelligence.
LAYER 03
Provider bidding behavior
Understanding how and when providers adjust bids reveals price elasticity patterns that can be monetized through yield management tools sold back to providers as a SaaS product: a second revenue flywheel.
Revenue Model
Three compounding revenue streams
01
Provider plans + patient convenience fee
Providers subscribe to a flat monthly plan (from a free tier to unlimited) to submit bids, with no per-transaction cut. Patients pay a small flat MedBid convenience fee when they book or confirm an appointment, then pay the provider directly onsite for the agreed price. Two predictable, recurring revenue lines instead of one variable commission.
02
B2B / Employer SaaS
Self-insured employers pay a PEPM (per employee per month) fee for MedBid as a healthcare cost-containment benefit. Recurring, predictable, high-margin revenue.
03
Data & Intelligence API
Healthcare price data sold via API to insurers, TPAs, benefit consultants, and researchers. Defensible, high-margin, grows in value as the transaction dataset compounds.
Let's talk about the opportunity.
MedBid is building the price-discovery layer for US cash-pay healthcare. We're focused on provider network development, HIPAA infrastructure, and go-to-market execution in San Jose and Las Vegas, two high-density bilingual markets with proven demand.
This page provides general information about MedBid's market opportunity and strategy. It is not an offer to sell, or a solicitation of an offer to buy, any securities.